Baruch Halpert
Chairman presso Terragenic International Ltd.
Profilo
Baruch Halpert is currently the Executive Chairman at Terragenic International Ltd.
He previously worked as a Director at Enlivex Therapeutics Ltd.
and holds a graduate degree from The University of Reading.
Posizioni attive di Baruch Halpert
| Società | Posizione | Inizio |
|---|---|---|
| Terragenic International Ltd. | Chairman | 01/01/2018 |
Precedenti posizioni note di Baruch Halpert
| Società | Posizione | Fine |
|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Director/Board Member | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Director/Board Member | - |
Formazione di Baruch Halpert
| The University of Reading | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
| Terragenic International Ltd. |
- Borsa valori
- Insiders
- Baruch Halpert
